Tekmira Pharmaceuticals tekmirapharm.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Tekmira is a leader in the development of the therapeutic agents based upon Nobel prize-winning breakthroughs in the field of gene silencing, known as RNA interference (RNAi). Tekmira's three lead RNAi product candidates target cholesterol management, cancer and Ebola infection.

Tekmira is a leader in the development of the therapeutic agents based upon Nobel prize-winning breakthroughs in the field of gene silencing, known as RNA interference (RNAi). Tekmira's three lead RNAi product candidates target cholesterol management...Show all

Company (Alive / Active)

Phone:

Fax:

100 - 8900 Glenlyon Parkway

Burnaby, V5J 5J8
British Columbia, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Tekmira Pharmaceuticals $0M Nov 30, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Tekmira Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
BDC Venture CapitalVenture CapitalMontreal, Quebec, Canada
BDC Healthcare Venture FundVenture CapitalMontreal, Quebec, CanadaOther Investors
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components Apr 19, 2016 Feb 20, 2018 Patent
Targeting lipids Oct 22, 2013 Nov 14, 2017 Patent
Method for the preparation of liposome encapsulated vincristine for therapeutic use Nov 20, 2013 Oct 31, 2017 Patent
Lipid containing formulations Jan 07, 2014 May 30, 2017 Patent
In vitro release assay for liposome encapsulated vincristine Dec 04, 2013 May 02, 2017 Patent
See all 19 patents